Expansion
Anuh Pharma Inaugurates F-10/1 Tarapur Facility, Lifting Annual Capacity to 2,925 MT
By News Desk ·
Key takeaways
- Anuh Pharma inaugurated its F-10/1 facility at M.I.D.C. Tarapur, Maharashtra, on November 15, 2026.
- The plant adds 525 metric tons per annum, lifting total capacity from about 2,400 MT to about 2,925 MT.
- The facility includes an additional 56 KL of reactor capacity, and full commercial operations are expected by December 2026.
Anuh Pharma inaugurated its F-10/1 manufacturing facility at M.I.D.C. Tarapur, Maharashtra, on November 15, 2026, adding 525 metric tons per annum of production capacity. ScanX reported that the expansion lifts the company's total approximate annual capacity from 2,400 metric tons to 2,925 metric tons.
Inside the F-10/1 Tarapur Expansion
The new plant is scheduled to become fully operational by December 2026, according to ScanX. The facility also includes an additional 56 KL of reactor capacity to strengthen manufacturing infrastructure.
Anuh Pharma disclosed the inauguration under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement follows earlier disclosures on the same project filed on October 13, October 16 and October 21, 2026. The company said the information is also available on its official website for investor reference.
Anuh Pharma is a publicly listed Indian manufacturer of active pharmaceutical ingredients and corticosteroids, founded in 1960 and headquartered in Mumbai, according to company records.
Anuh Pharma's Regulatory and Capacity Record
According to akta.pro company records, Anuh Pharma received WHO Pre-Qualification for Amodiaquine Hydrochloride USP in May 2026, qualifying it as an eligible supplier for WHO-procured and donor-funded anti-malarial programmes. The same records list a fourth capacity expansion of 400 MTPA completed in 2024, bringing total capacity to 2,200 MTPA at that time.
Deals That Preceded the Tarapur Inauguration
On October 16, 2026, Anuh Pharma signed an asset transfer agreement to acquire Vanquest Pharma's Tarapur manufacturing facility for ₹72.90 crore, adding 525 MTPA of API and intermediate production capacity, ScanX reported. The consideration was in cash with no share issuance.
On October 13, 2026, the company's board approved a loan of up to ₹75 crore to purchase manufacturing assets and expand production capacity, subject to final terms and regulatory clearances, according to ScanX.
December 2026 Target for Full Operations
Full commercial operations at the F-10/1 facility are expected to commence by December 2026, ScanX reported.